Chengdu Shengnuo Biopharm Co Ltd sell "Icatibant"
Basic Information
1.4K
90
30
3.4(29)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Icatibant
Substance
Manufacturer(s)
Specifications
- CAS Number: 130308-48-4
- Chemical Formula: C59H89N19O13S
- Formulation Type: Synthetic peptidomimetic decapeptide (ten amino acids)
- IUPAC Name: (2S)-2-[[(2S,3aS,7aS)-1-[(3R)-2-[(2S)-2-[[(2S)-2-[[2-[[(2S,4R)-1-[(2S)-1-[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-
- EC Number:
- Molecular Weight: 1304.5
- Regulatory Status: Approved in the EU for hereditary angioedema; holds US orphan drug status, FDA-approved August 25, 2011
- Application: Specific bradykinin B2 receptor antagonist for treating hereditary angioedema and investigated for other bradykinin-mediated conditions
Other Information
Additional Description:
A synthetic, ten-amino-acid peptidomimetic drug acting as an effective, specific bradykinin B2 receptor antagonist, approved in the EU for hereditary angioedema and under investigation for other conditions where bradykinin plays a significant role. It holds orphan drug status in the US and received FDA approval on August 25, 2011, for HAE (hereditary angioedema).
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment